about
Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseasePharmacological significance of triazole scaffold.Rational drug discovery design approaches for treating Parkinson's disease.2-Benz-yloxy-1,2,4-triazolo[1,5-a]quinazolin-5(4H)-one.Antimicrobial activity of newly synthesized methylsulfanyl-triazoloquinazoline derivatives.Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Selective adenosine A2A receptor antagonists
@ast
Selective adenosine A2A receptor antagonists
@en
Selective adenosine A2A receptor antagonists
@nl
type
label
Selective adenosine A2A receptor antagonists
@ast
Selective adenosine A2A receptor antagonists
@en
Selective adenosine A2A receptor antagonists
@nl
prefLabel
Selective adenosine A2A receptor antagonists
@ast
Selective adenosine A2A receptor antagonists
@en
Selective adenosine A2A receptor antagonists
@nl
P2093
P1433
P1476
Selective adenosine A2A receptor antagonists
@en
P2093
A Monopoli
B Cacciari
P G Baraldi
P356
10.1016/S0014-827X(01)01024-2
P407
P577
2001-01-01T00:00:00Z